Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease

DIANA, ANDREA;SOGOS, VALERIA;
2009-01-01

Abstract

Imbalance of gamma amynobutyric acid (GABA) and related modulators has been indicated as an important factor in the pathogenesis of amyotrophic lateral sclerosis (ALS). In this context, the role and mechanism of action of gabapentin and baclofen (GABA agonistI). This is the first systematic review addressing the benefit of gabapentin or baclofen by means of clinical trials for the treatment of ALS.
2009
1
Sì, ma tipo non specificato
Protocol
Diana, Andrea; Sogos, Valeria; Bongioanni, P; Miller, R; Moore, D.
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
5
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Questionario e social

Condividi su:
Impostazioni cookie